Skin Cancer

Researchers found that nearly 75 percent of sunscreen products contain less SPF than labeled, and the Environmental Working Group (EWG) is working to have that changed.

Patients with in immunotherapy-naïve and pretreated patients with advanced melanoma saw a 50 percent overall response rate (ORR) when adding a formulation of the Coxsackievirus A21 (CVA21; CAVATAK®) to Yervoy (ipilimumab) – a combination which was well-tolerated.

A plan for remembering your loved one when times get tough.

Non-invasive imaging devices can help dermatologists examine the skin and a lesion without a biopsy, which requires cutting of the skin.

Since being diagnosed with desmoplastic melanoma in 2016, Holly Rowe has teamed up with the Melanoma Research Foundation to spread awareness of skin cancer.

As we approach summer, a melanoma survivor recovers from her fresh wounds and shares her thoughts.

All is NOT fair in love and war

Immunotherapy showed improved survival benefits for stage 3 and 4 melanoma, but it came at a price of greater toxicity, according to a randomized, double-blind phase 3 study that compared 10 mg/kg Yervoy (ipilimumab) or a lower dose of the anti-CTLA-4 anticlonal antibody.

Breast cancer survivor looks back and describes her radiation treatment and shares her tips.

A two-time cancer survivor, breast cancer and melanoma, discusses the empty nest process and cancer.

Cancer survivor discusses interviewing for jobs and returning to employment after surviving breast cancer and melanoma.

What about hope? Don’t kill hope. Breast cancer and melanoma survivor shares what helped at the time of diagnosis and early on in her cancer treatment.

An ongoing trial studying Keytruda (pembrolizumab) with the first-in-class IDO1 inhibitor epacadostat (INCB024360) can mean drastic change for patients with melanoma.

Bavencio (avelumab), a PD-L1-inhibitor, gained approval by the Food and Drug Administration (FDA) for some patients with Merkel cell carcinoma.

Kiran K. Turaga explains that, even with all the advancements and novel treatments in melanoma, surgery is still critical.

Breast cancer and melanoma survivor says you are allowed to feel what you are feeling, whatever that is.

Robert Andtbacka, M.D., C.M., discusses the importance of communication between patients and health care professionals during melanoma surgery.

Breast cancer and melanoma survivor ponders the heart of the cancer diagnosis--a lifetime of ongoing uncertainty.

Did you know that melanoma isn’t just skin cancer? It can also develop in the eyes (ocular melanoma) and in the mucous membranes of the body (mucosal melanoma).

A breast cancer and melanoma survivor remembers the emotions and experiences after surgeries, chemotherapy and radiation are finished.

Breast cancer and melanoma survivor vents about her weight gain frustrations several years out from her original cancer diagnosis.

Two-time survivor reflects about the cancer experience and offers perspective and hope.

Omid A. Hamid, M.D., of The Angeles Clinic and Research Institute and Jason J. Luke, M.D., of University of Chicago Medicine, share treatment approaches on the horizon for patients with melanoma.

Breast cancer survivor shares her chemotherapy tips for patients who need chemotherapy.

Legally preventing people under the age of 18 to go indoor tanning may reduce the number of Americans with melanoma, ultimately decreasing treatment costs, according to a recent study.

Cancer survivor discusses the emotional difficulties that came with going back to work after surviving breast cancer and skin cancer.

Tasigna and Mekinist is showing promise for the treatment of patients with BRAF/NRAS wild-type melanoma, according to a recent study.

Two-time cancer survivor just doesn't trust the body that betrayed her--twice.

Group exercise programs are beneficial to survivors of cancer, and can offer motivation from peers to continue living a healthy lifestyle.

Three recent trials showed that Keytruda had a durable response for patients with a rare subtype of melanoma.